144 related articles for article (PubMed ID: 30026276)
1. Medium-Chain Acylcarnitines Are Associated With Cardioembolic Stroke and Stroke Recurrence.
Seo WK; Jo G; Shin MJ; Oh K
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2245-2253. PubMed ID: 30026276
[TBL] [Abstract][Full Text] [Related]
2. Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification.
Zoni E; Minoli M; Bovet C; Wehrhan A; Piscuoglio S; Ng CKY; Gray PC; Spahn M; Thalmann GN; Kruithof-de Julio M
BMC Cancer; 2019 Dec; 19(1):1216. PubMed ID: 31842810
[TBL] [Abstract][Full Text] [Related]
3. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization.
Peng M; Liu L; Jiang M; Liang C; Zhao X; Cai Y; Sheng H; Ou Z; Luo H
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():12-8. PubMed ID: 23816563
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of medium-chain acyl-CoA dehydrogenase deficiency detected by newborn screening.
Hsu HW; Zytkovicz TH; Comeau AM; Strauss AW; Marsden D; Shih VE; Grady GF; Eaton RB
Pediatrics; 2008 May; 121(5):e1108-14. PubMed ID: 18450854
[TBL] [Abstract][Full Text] [Related]
5. Medium & long-chain acylcarnitine's relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study.
Zheng DM; An ZN; Ge MH; Wei DZ; Jiang DW; Xing XJ; Shen XL; Liu C
Lipids Health Dis; 2021 Nov; 20(1):151. PubMed ID: 34727932
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Profile for Prediction of Ischemic Stroke in Chinese Hypertensive Population.
Guo X; Li Z; Zhou Y; Yu S; Yang H; Zheng L; Liu Y; Sun Y
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1062-1069. PubMed ID: 30642666
[TBL] [Abstract][Full Text] [Related]
7. A targeted metabolomic profiling of plasma acylcarnitines in nonalcoholic fatty liver disease.
Chang Y; Gao XQ; Shen N; He J; Fan X; Chen K; Lin XH; Li HM; Tian FS; Li H
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7433-7441. PubMed ID: 32706083
[TBL] [Abstract][Full Text] [Related]
8. Targeted Metabolomic Biomarkers for Stroke Subtyping.
Lee EJ; Kim DJ; Kang DW; Yang W; Jeong HY; Kim JM; Ko SB; Lee SH; Yoon BW; Cho JY; Jung KH
Transl Stroke Res; 2024 Apr; 15(2):422-432. PubMed ID: 36764997
[TBL] [Abstract][Full Text] [Related]
9. Potential serum biomarkers and metabonomic profiling of serum in ischemic stroke patients using UPLC/Q-TOF MS/MS.
Sun H; Zhao J; Zhong D; Li G
PLoS One; 2017; 12(12):e0189009. PubMed ID: 29228037
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of serum metabolites and risk of ischemic stroke.
Sun D; Tiedt S; Yu B; Jian X; Gottesman RF; Mosley TH; Boerwinkle E; Dichgans M; Fornage M
Neurology; 2019 Apr; 92(16):e1890-e1898. PubMed ID: 30867269
[TBL] [Abstract][Full Text] [Related]
11. Interventional Left Atrial Appendage Closure Affects the Metabolism of Acylcarnitines.
Fastner C; Behnes M; Sartorius B; Wenke A; Lang S; Yücel G; Sattler K; Rusnak J; Saleh A; Barth C; Mashayekhi K; Hoffmann U; Borggrefe M; Akin I
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414920
[TBL] [Abstract][Full Text] [Related]
12. A Multi-Cohort Metabolomics Analysis Discloses Sphingomyelin (32:1) Levels to be Inversely Related to Incident Ischemic Stroke.
Lind L; Salihovic S; Ganna A; Sundström J; Broeckling CD; Magnusson PK; Pedersen NL; Siegbahn A; Prenni J; Fall T; Ingelsson E; Ärnlöv J
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104476. PubMed ID: 31806450
[TBL] [Abstract][Full Text] [Related]
13. Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.
Floegel A; Kühn T; Sookthai D; Johnson T; Prehn C; Rolle-Kampczyk U; Otto W; Weikert C; Illig T; von Bergen M; Adamski J; Boeing H; Kaaks R; Pischon T
Eur J Epidemiol; 2018 Jan; 33(1):55-66. PubMed ID: 29181692
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics predicts stroke recurrence after transient ischemic attack.
Jové M; Mauri-Capdevila G; Suárez I; Cambray S; Sanahuja J; Quílez A; Farré J; Benabdelhak I; Pamplona R; Portero-Otín M; Purroy F
Neurology; 2015 Jan; 84(1):36-45. PubMed ID: 25471397
[TBL] [Abstract][Full Text] [Related]
15. Profiling of Acylcarnitines in First Episode Psychosis before and after Antipsychotic Treatment.
Kriisa K; Leppik L; Balõtšev R; Ottas A; Soomets U; Koido K; Volke V; Innos J; Haring L; Vasar E; Zilmer M
J Proteome Res; 2017 Oct; 16(10):3558-3566. PubMed ID: 28786289
[TBL] [Abstract][Full Text] [Related]
16. Plasma phospholipid arachidonic acid and lignoceric acid are associated with the risk of cardioembolic stroke.
Chung HK; Cho Y; Do HJ; Oh K; Seo WK; Shin MJ
Nutr Res; 2015 Nov; 35(11):1001-8. PubMed ID: 26452419
[TBL] [Abstract][Full Text] [Related]
17. Urinary metabolomic study of non-small cell lung carcinoma based on ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Wu Q; Wang Y; Gu X; Zhou J; Zhang H; Lv W; Chen Z; Yan C
J Sep Sci; 2014 Jul; 37(14):1728-35. PubMed ID: 24771673
[TBL] [Abstract][Full Text] [Related]
18. Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study.
Sun L; Liang L; Gao X; Zhang H; Yao P; Hu Y; Ma Y; Wang F; Jin Q; Li H; Li R; Liu Y; Hu FB; Zeng R; Lin X; Wu J
Diabetes Care; 2016 Sep; 39(9):1563-70. PubMed ID: 27388475
[TBL] [Abstract][Full Text] [Related]
19. Detection of inborn errors of fatty acid oxidation from acylcarnitine analysis of plasma and blood spots with the radioisotopic exchange-high-performance liquid chromatographic method.
Schmidt-Sommerfeld E; Penn D; Duran M; Bennett MJ; Santer R; Stanley CA
J Pediatr; 1993 May; 122(5 Pt 1):708-14. PubMed ID: 8496747
[TBL] [Abstract][Full Text] [Related]
20. Medium- and long-chain acylcarnitines are associated with osteoarthritis severity and arterial stiffness in end-stage osteoarthritis patients: a case-control study.
Tootsi K; Kals J; Zilmer M; Paapstel K; Ottas A; Märtson A
Int J Rheum Dis; 2018 Jun; 21(6):1211-1218. PubMed ID: 29314768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
